ArticleThe Lancet regional health. Western Pacific2026
Effect of a comprehensive package based on combined C-reactive protein and serum amyloid A point-of-care testing on antibiotic prescribing for acute respiratory tract infections at village clinics in China: a cluster randomised controlled trial.
Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06568432 (Effect of C-reactive Protein and Serum Amyloid A Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections at Village Clinics in China), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of C-reactive Protein and Serum Amyloid A Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections at Village Clinics in China: a Study Protocol for a Cluster Randomised Controlled Trial
Who cites it
1 citing paper in PubMed.
- Can combined biomarker testing shape the future of primary care antibiotic prescribing?The Lancet regional health. Western Pacific · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antibiotic misuse is a key driver of antimicrobial resistance globally, with high rates of inappropriate use observed in rural China. We evaluated the effectiveness of a comprehensive package based on quantified point-of-care testing (POCT) for C-reactive protein and serum amyloid A (CRP&SAA) in reducing inappropriate antibiotic use for acute respiratory infections (ARIs) in village clinics in rural China. Methods: We conducted a pragmatic, parallel-group, cluster-randomised controlled trial at 40 village clinics in Xiantao City, Hubei Province, China, over a 6-month intervention period. Village clinics were randomly assigned (1:1) to provide a comprehensive package based on CRP&SAA POCT, or usual care. Randomisation was stratified by township. Eligible consultations were patients of all ages with a diagnosis of ARI or acute respiratory symptoms in village clinics. The primary outcome was the proportion of initial patient consultations diagnosed with ARIs resulting in any antibiotic prescriptions from village doctors in the intention-to-treat population. The 30-day hospital admission rate for ARIs or sepsis following the initial ARI consultation was measured as a safety outcome. This trial is registered with ClinicalTrials.gov, NCT06568432. Findings: Forty village clinics were randomly assigned, 20 to the intervention group (n = 17,754) and 20 to the control group (n = 17,354). A total of 7.4% consultations (1311 out of 17,754) performed the test in the intervention group. A total of 9001 (50.70%) consultations in the intervention group and 11,715 (67.51%) consultations in the control group resulted in antibiotic prescriptions (adjusted relative risk 0.80 [95% CI 0.78-0.82; p < 0.001]; adjusted risk difference -13% [95% CI -15 to -12; p < 0.001]). The 30-day hospitalisation rate for ARIs or sepsis did not differ significantly (0.32% in the control group versus 0.35% in the intervention group; adjusted relative risk 0.94 [95% CI 0.59-1.48; p = 0.78]; adjusted risk difference 0% [95% CI 0-0; p = 0.78]). Interpretation: The interventions can safely and effectively reduce antibiotic use among patients with ARIs in village clinics in rural China. Future implementation efforts should further examine the barriers and facilitators to adopting POCT within specific health system contexts and service delivery settings, and identify cost-effective strategies to scale up POCT in primary care. Funding: The University of Toronto-Huazhong University of Science and Technology JOINT SEED FUND and the Medical Young Top-notch Talent Cultivation Program of Hubei Province.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.